It’s time to kiss the medical device tax goodbye, again.

The stopgap spending deal that cleared the Senate and the House on Monday contained an unexpected surprise for medtech: a two-year suspension of the 2.3% medical device tax. President Trump signed off on the bill Monday night.

“This suspension is good news for American patients and American innovation,” Scott Whitaker, president and CEO of AdvaMed said in a statement the organization issued Monday night. “Congress’ action – just days before medical technology innovators were set to start cutting checks to the IRS – means funds will not be diverted from current investments in jobs, capital improvements, and research into new treatments and cures.”

Still, Whitaker acknowledged that the two-year suspension is “only an interim step toward the truly needed action by Congress to fully repeal this tax.” He said AdvaMed would continue to work with lawmakers on a bipartisan basis to achieve that end goal of permanent relief from the levy.

Source: It’s Time to Kiss the Medical Device Tax Goodbye | MDDI Online

by: Amanda Pedersen is Qmed’s news editor.  Contact her at amanda.pedersen@ubm.com.